Evoke Pharma Inc (EVOK)
Evoke Pharma is a pharmaceutical company focused primarily on the development and commercialization of drugs to treat gastrointestinal disorders and diseases. Co. is focused on developing its primary product, Gimoti (metoclopramide) nasal spray. Gimoti is a dopamine antagonist / mixed 5-HT3 antagonist / 5-HT4 agonist for the relief of symptoms associated with acute and recurrent diabetic gastroparesis. Gimoti is a formulation of metoclopramide providing delivery by nasal spray administration. Co. is party to a commercial services agreement with Eversana Life Science Services, LLC, or Eversana, pursuant to which Eversana commercializes and distributes Gimoti in the U.S.
Company Name: |
Evoke Pharma Inc |
Website: |
www.evokepharma.com |
Sector: |
Drugs & Pharmaceuticals |
Number of ETFs Holding EVOK: |
1 |
Total Market Value Held by ETFs: |
$17517 |
Total Market Capitalization: |
$5.00M |
% of Market Cap. Held by ETFs: |
0.35% |
|
|
March 28, 2024 1:47 PM Eastern
Strong Buy (4.00 out of 4)
100th percentile
|
|